SkylineDx announces commercial launch Merlin™ Assay as CE-IVD kit in Europe

ROTTERDAM, Netherlands and SAN DIEGO, Sept. 1, 2022 /PRNewswire/ — Today, SkylineDx, a leading molecular diagnostics company, announces the commercial launch of Merlin Assay as CE-IVD distributable test kit in Europe. Merlin Assay identifies melanoma (skin cancer) patients that have a…

Click here to view original post